PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.59

+1.4%

1:10 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (3591)	6/19/1998 5:42:00 PM
From: Zebra 365	Read Replies (1) of 9523

"I don't think analysts would take into account Zeldox's future sales when the drug is not yet approved by the FDA" Anthony the analysts might not but I think the market was counting on Zeldox to be one of the "big 3" pipeline drugs with impact on the income statement within one year. After all, the stock ran up on the Viagra expectations when it had "yet to be approved". The drugs to treat schizophrenia are in the "early years" like before there was Prozac for treating depression. Prozac was not a huge hit because of marketing but because it was a true step forward as it was an effective drug with much fewer side effects. Prozac had 45% of the anti-depressant market 18 months after it's release. The newer anti-schizophrenia drugs may seem to be expensive with a small market, but they often mean the difference between being in an institution or being a "street-person" and being a productive functional citizen. Just like we had to beg patients to stay on the old antidepressants because of side effects, most schizophrenics do not like to stay on their medications today because they feel better without them. Side effects. I think the effect of this Zeldox delay on the stock will be large. As the enthusiasm and the script numbers for Viagra dwindle over time to a sustainable level, investors and the market will look to the "pipeline" to support this high forward-looking P/E. That pipeline now has a significant dent in it. Still a great company, just not as great a stock with this news. And the day's trading did not have the full benefit of this news from the open. Zebra

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next